Crystalline forms of N-(4-((3-(2-amino-4-pyrimidinyl) - 2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1 -phthalazinamine pharmaceutically acceptable salts and uses thereof

• 收藏
• 分享

专利权人:

Amgen Inc.

发明人:

Chaves, Mary,Bio, Matthew,Peterson, Matthew

申请号：

AU2014357545

公开号：

AU2014357545A1

申请日:

2014.11.25

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The present invention relates to crystalline forms and co-crystal forms of pharmaceutically acceptable salts of the compound, N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine (AMG 900, and pharmaceutical compositions comprising said crystalline and co-crystal forms thereof. The invention further provides uses of the crystalline foms and compositions, to treat cancer, including various types of solid tumors and hematologic cancer including myeloma and leukemia.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/